Evidence map›Paper›PMID 38867031›Full record

ArticleGeroScience2024

Intrinsic aerobic capacity modulates Alzheimer's disease pathological hallmarks, brain mitochondrial function and proteome during aging.

Benjamin A Kugler, Colton R Lysaker, Edziu Franczak, Brittany M Hauger, Vivien Csikos, Julia A Stopperan, Julie A Allen, John A Stanford, Lauren G Koch, Steven L Britton and 2 more

Abstract read
In one paragraph

Article in GeroScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Loss of ovarian function and estrogen therapy remodel the brain's synaptic and metabolic proteome.American journal of physiology. Regulatory, integrative and comparative physiology · 2026
    Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Benjamin A KuglerUniversity of Kansas Medical Center Department of Cell Biology and Physiology and Internal Medicine, Kansas City, KS, USA.
Colton R LysakerUniversity of Kansas Alzheimer's Disease Center and Department of Neurology, Kansas City, KS, USA.
Edziu FranczakUniversity of Kansas Medical Center Department of Cell Biology and Physiology and Internal Medicine, Kansas City, KS, USA.
Brittany M HaugerUniversity of Kansas Alzheimer's Disease Center and Department of Neurology, Kansas City, KS, USA.
Vivien CsikosUniversity of Kansas Alzheimer's Disease Center and Department of Neurology, Kansas City, KS, USA.
Julia A StopperanUniversity of Kansas Alzheimer's Disease Center and Department of Neurology, Kansas City, KS, USA.
Julie A AllenUniversity of Kansas Medical Center Department of Cell Biology and Physiology and Internal Medicine, Kansas City, KS, USA.
John A StanfordUniversity of Kansas Medical Center Department of Cell Biology and Physiology and Internal Medicine, Kansas City, KS, USA.
Lauren G KochDepartment of Physiology and Pharmacology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, USA.
Steven L BrittonDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.
John P ThyfaultUniversity of Kansas Alzheimer's Disease Center and Department of Neurology, Kansas City, KS, USA.
Heather M WilkinsUniversity of Kansas Alzheimer's Disease Center and Department of Neurology, Kansas City, KS, USA. hwilkins@kumc.edu.ORCID 0000-0003-4563-4544

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
Translational Regulation in Normal Erythropoiesis and Diamond Blackfan AnemiaP20GM121293 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Samrat Roy Choudhury · 2017 to 2026
$27.6M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SWERDLOW, RUSSELL H. · 2011 to 2020
$16.6M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
longitudinal assessment of stress and stress-related concepts across a behavioral weight loss interventionP20GM144269 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI John P Thyfault, STEVEN A WEINMAN · 2022 to 2026
$14.9M
Relationships between APP and MitochondriaR01AG078186 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Heather M. Wilkins · 2023 to 2026
$2.9M
Ketogenic Oscillations and Neurometabolic HealthspanR01AG069781 · NIA · UNIVERSITY OF MINNESOTA · PI CRAWFORD, PETER A, THYFAULT, JOHN P · 2020 to 2024
$2.3M
Divergence in Aerobic Capacity Drives Liver and Brain HealthR01DK121497 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI THYFAULT, JOHN P · 2019 to 2022
$2.2M
Multidisciplinary Research Training Program in Alzheimer's Disease and Related DisordersT32AG078114 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Sandra A Billinger, Eric Dennis Vidoni · 2022 to 2026
$1.2M
Translating Obesity, Metabolic Dysfunction and Comorbid Disease StatesT32DK128770 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI John P Thyfault, Douglas E Wright · 2022 to 2026
$806k
Relationship between Amyloid beta and BioenergeticsR00AG056600 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WILKINS, HEATHER M. · 2020 to 2022
$747k
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosisI01BX002567 · VA · KANSAS CITY VA MEDICAL CENTER · PI THYFAULT, JOHN P · 2015 to 2025
–
BLRD VA I01 BX002567Kansas Center for Metabolism and Obesity Research Center P20GM144269Margaret "Peg" McLaughlin and Lydia A. Walker Opportunity Fund P30AG035982NIA NIH HHS P30 AG035982NIA NIH HHS R00AG056600NIA NIH HHS R01AG069781NIA NIH HHS R01 AG078186NIA NIH HHS R01AG078186NIA NIH HHS T32 AG078114NIA NIH HHS T32AG078114NIDDK NIH HHS R01 DK121497NIDDK NIH HHS R01DK121497NIDDK NIH HHS T32 DK128770NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM121293NIGMS NIH HHS P20 GM144269NIGMS NIH HHS R24 GM137786VA Merit Review Grant 1I01BX002567
6 · The paper itself

Abstract

Low aerobic capacity is strongly associated with all-cause mortality and risk for Alzheimer's disease (AD). Individuals with early dementia and AD have lower aerobic capacity compared to age-matched controls. The mechanism by which aerobic capacity influences AD risk is unknown but is likely mediated by sexual dimorphism and tissue-level differences in mitochondrial energetics. Here, we used rats selectively bred for large differences in intrinsic aerobic exercise capacity. Brain tissue from 18-month and 24-month-old female and male low-capacity runner (LCR) and high-capacity runner (HCR) rats were analyzed for markers of mitochondrial function and AD-associated pathologies. LCR rats, irrespective of sex, exhibited a greater increase in brain amyloid beta (Aβ

Indexed as

AgingAlzheimer DiseaseAmyloid beta-PeptidesBrainMitochondriaProteomeAnimalsDisease Models, AnimalFemaleMalePhosphorylationPhysical Conditioning, AnimalRatstau ProteinsAmyloid beta-PeptidesProteometau ProteinsAerobic capacityAgingAlzheimer’s diseaseAmyloid betaBioenergeticsMitochondriaTau

Identifiers

PMID38867031
PMCPMC11336007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.